News

Discussion includes packaging reduction act, medical aid in dying, PFAS limits in drinking water and climate change policies.
Bio-Techne appears overvalued despite strong revenue growth, solid debt coverage, and looming U.S. healthcare funding cuts.
Montgomery Advertiser on MSN19mOpinion
The path not taken | BRIAN LYMAN
Alabama can’t run safe prisons; rural residents struggle to access health care and our lax gun laws have created ...